S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Morphotek and Sorrento Therapeutics Sign an Exclusive Research and Option Agreement to Generate and Develop Morphotek Antibody Drug Conjugates (2014/6/25)|
|Sorrento Therapeutics Announces Confidential Submission of Draft Registration Statement for Initial Public Offering (IPO) of its Wholly-owned Subsidiary Ark Animal Health with the SEC (2014/6/23)|
|Sorrento to Present at BIO Business Forum|
|Sorrento Awarded up to $2.6 Million from the National Institutes of Health (NIH) for the Development of New Anti-bacterial Bispecific Antibodies and Antibody Formulated Drug Conjugates (2014/7/1)|
|Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor (2014/7/21)|
|Sorrento Announces the Unexpected Death of its Chief Business Officer (2014/7/31)|
|Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics|
|Sorrento Therapeutics Appoints Douglas Ebersole to its Board of Directors (2014/8/8)|
|Sorrento Therapeutics to Present at Two Healthcare Conferences (2014/9/5)|
|Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) (2014/8/26)|
Click above to view more mutual fund data and stats for srne - Sorrento Therapeutics Inc.